The administration of VCE-003.2 to lipopolysaccharide (LPS)-lesioned mice (a model for Parkinson’s disease) attenuated the loss of tyrosine hydroxylase (TH)-containing nigrostriatal neurons, and in particular, the intense microgliosis caused by LPS in the substantia nigra [37]. The gene discussed is TH; the disease is Parkinson disease.